Unichem Group Launches "All Together Now" Legacy Documentary in the UK

In a filmic experience that touched the hearts of many throughout the nation, healthcare innovators Unichem Group, in partnership with Luex Healthcare UK, launched their acclaimed documentary,“A"Come Together Now," for public awareness.

In a realm where heritages are frequently passed down,thisone that was achieved amidst challenges, dedication, and the unspoken resilience of a family that would not collapse.

At the heart of the narrative is Dr. H.D. Mohan, a person who left school at 12 and was uprooted during the Partition of Sindh in 1947, an event that marked one of the most harrowing mass movements in recent history.

Numerous Sindhi Hindus, like him, left their native land during a period of turmoil and bloodshed, ultimately discovering safety and direction in Africa.

Dr. Mohan traveled to Liberia in West Africa, where he reestablished his life and established a successful pharmaceutical company. He didn't merely sell medications; he became the reliable link between West Africa and major global companies such as Pfizer and Boots, assisting in introducing international standards and life-saving products to new areas. For Dr. Mohan, this was not just a business venture, but a mission: to heal with respect, to serve with modesty, and to lead with passion.

But in 1989, Liberia was engulfed by civil war. The business was lost. Once more, everything was destroyed. Records were gone, assets wiped out, twice uprooted, twice left with nothing, yet he started over. This time, in Ghana, not with resentment, but withboundless humility. Not to gain riches, but to regain wellness.

With him during the company's most critical years was his son, Sir Raj Mohan, currently serving as the Executive Chairman of Unichem Group.

A powerful yet subtle figure, Sir Raj, during the civil unrest in Liberia, played a key role in rebuilding the company from scratch in Ghana in 1992, bringing with it a stronger spiritual dimension.

He has brought spiritual depth, ethical clarity, and a sense of purpose across generations to the company. With his leadership, Unichem evolved from a family-owned business into a true business family. And it is by his consistent guidance that the company now has a presence throughout the continent.

Extending this vision around the world is Sunil Mohan, CEO of Luex Healthcare UK, whose international leadership has turned the Luex name into a representation of medical reliability and moral affordability.

In the past 30 years, with Mr. Sunil at the helm, Luex's main products have become essential in Africa, such as: Luex Cough Syrup – Preferred by more than 100 million individuals over the last 20 years.

Other options include Mycolex – an antifungal treatment endorsed by the Dermatology Society, and Metrolex-F – a reliable therapy for infectious diarrhea, known for saving millions of lives.

Backing the larger vision is Vishaal Mohan, the oldest of the Mohan brothers. Mr. Vishaal serves as CEO of Unichem Ghana, and his strategic guidance keeps steering the company's direction with honesty as he leads one of the most energetic and capable pharmaceutical marketing teams in the region.

Among the leading figures is Jason Nana Yaw Mohan, CEO of Unichem Industries, who is a well-known and influential presence in the nation's healthcare sector. With his charm, humility, and strong dedication to building a lasting impact, Jason has been instrumental in keeping the Unichem narrative closely tied to the communities it supports, not only through pharmacies but also within local areas and worldwide.

In addition to its filmic excellence, the documentary stands as an archival achievement and includes more than 50 perspectives from various sectors within the healthcare field:

From pharmacists to decision-makers, physicians to suppliers, government representatives to local collaborators, each provides a perspective on the human essence within the brand.

Among the numerous strong acknowledgments: Dr. Bernard Toboh, prominent urologist:They have established themselves as a pioneer in unyielding Quality Healthcare.”

Presented by Natalie Fort, the opening screenings highlighted that Unichem is more than just a pharmaceutical company. It is a dynamic narrative, reflecting perseverance, transformation, and innovative leadership.

And it serves as a reminder that certain legacies are not passed down — they are gained, each and every day.

Read More

150+ Pharma Firms Registered in Nigeria — ACPN

The Association of Community Pharmacists of Nigeria (ACPN) has revealed that Nigeria currently has more than 150 licensed pharmaceutical manufacturers, with at least five of them accredited by the World Health Organization (WHO) for Good Manufacturing Practice (GMP), marking a significant achievement that highlights the sector's increasing capabilities amid ongoing obstacles.

This information was disclosed before the organization's 44th National Conference, which is set to take place in Awka, Anambra State, from July 22 to 27, 2025.

During a pre-conference media briefing, the National Chairman of ACPN, Ambrose Ezeh, told journalists that the pharmaceutical industry is steadily progressing towards becoming a multi-billion-dollar sector.

"Never doubt it, the pharmaceutical industry keeps expanding despite all challenges," Pharm. Local manufacturers, including well-known Nigerian investors, are constructing Active Pharmaceutical Ingredient (API) facilities with investments reaching tens of millions of dollars.

These initiatives are transforming the framework of the game and contributing to the establishment of pharmaceutical security in Nigeria.

He provided examples of major pharmaceutical companies, including Fidson Healthcare, which has been significantly involved in the manufacture of anti-retroviral medications, Emzor Pharmaceuticals, which recently established a Cephalosporin facility, and Jawa Pharmaceuticals, an Indian firm that has introduced a beta-lactam production unit in Nigeria.

As per Ezeh, due to recent funding and planned growth initiatives, the sector is expected to increase from its present estimated worth of $2 billion to up to $10 billion within the next five years.

The ACPN also praised Codix Healthcare for setting up a local facility to produce in-vitro diagnostic kits and medical supplies, enhancing the nation's ability to be self-sufficient in critical health products.

He mentioned that although there have been improvements, the association pointed out that the industry still needs intentional assistance from the government.

We call on the government at every level to assist pharmaceutical producers by offering specific incentives, such as access to equipment and raw materials that comply with GMP requirements.

"Local production offers significant potential for generating employment, fostering economic development, enhancing international trade, and strengthening national security," Ezeh stated.

He cautioned that poorly executed policies, like the contentious MEDIPOOL initiative, might hinder advancement if those involved, such as pharmacists, are not adequately included in discussions.

"Policies should not be created independently. The Federal Ministry of Health needs to engage more with stakeholders involved in pharmacy practice prior to implementing changes," he added.

The ACPN also urged the government to revise the Fake Drug Act to impose harsher consequences for violators and to completely enforce the National Drug Distribution Guidelines (2015), designed to clean up Nigeria's disordered pharmaceutical supply network.

Shifting focus to professional politics within the health sector, Pharm. Ezeh voiced his frustration regarding what he referred to as "the ongoing subordination of pharmacists and other healthcare professionals by physicians," whom he blamed for shaping policies in their own interest.

He stated: "The government keeps favoring doctors who desire that every title, position, or benefit in the healthcare sector be reserved solely for members of the Nigerian Medical Association (NMA)."

This challenges the independent judgment of other skilled healthcare practitioners.

Ezeh also raised the question of why only doctors are selected as Chief Executive Officers of federal health institutions, and expressed concern that even though a consultant level for pharmacists was introduced in 2015, many hospitals continue to refuse to adopt it.

We, as a profession, have invested millions in training for the fellowship program that paves the way to becoming a consultant, but we face obstacles at every stage," he stated. "Ironically, doctors who get government-sponsored training frequently leave the country, while pharmacists who finance their education themselves are blocked from career advancement.

The group also took a strong position against the proposed National Health Facility Regulatory Authority (NHFRA) Bill that is currently under consideration by the National Assembly, cautioning against any effort to combine the Pharmacy Council of Nigeria (PCN) with other regulatory agencies.

It is one of the factors that enabled Nigeria to reach WHO Maturity Level 3 in medicine regulation. A merger would reduce our efficiency and disrupt years of advancement.

He mentioned that international best practices in nations such as the United States, the United Kingdom, Canada, and South Africa involve having independent pharmacy councils to ensure professional standards and public safety.

With the Awka conference approaching, the ACPN reaffirmed its dedication to reforms aimed at guaranteeing the availability, access, and affordability of safe and high-quality medicines in Nigeria.

The vision is distinct," Ezeh stated. "We will continue to advance, as the scripture mentions, 'I, the Lord, bring down the tall tree and cause the low tree to grow tall, I have spoken and I will accomplish it'.

Provided by SyndiGate Media Inc. (Syndigate.info).

Read More